Bristol-Myers Squibb Company
| Name | Area | Department | Start Year | Stop Year | Advisor |
|---|---|---|---|---|---|
| David G. Harden | Ion channel, GPCR, and Enzyme drug targets | Anthony Albert Grace (grad student) | |||
| Matthew A. Seager | Alzheimer's disease, schizophrenia, depression, learning, memory, cognition, drugs of abuse, hippocampus |